Takashi Nagai

6PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
Durable Progression-Free and Treatment-Free Survival After Nivolumab Plus Ipilimumab Therapy in Metastatic Renal Cell Carcinoma: A Real-World Study with a 5-Year Minimum Follow-Up.

|Mar 26, 2026
Enhanced magnetic hyperthermia using anti-PD-L1 antibody-conjugated magnetoliposomes in a murine subcutaneous bladder cancer model.

Masakazu Gonda, Noriyasu Kawai, Daiki Ishikawa

|Jan 05, 2026
Establishment of a Patient-Derived Xenograft Model of a Testicular Yolk Sac Tumor.

Nobuhiko Shimizu, Taku Naiki, Aya Naiki-Ito

|Nov 01, 2024
Learning curve of multiple surgeons for robot-assisted radical prostatectomy using the cumulative sum method: a retrospective single-institution study.

Takashi Nagai, Toshiki Etani, Nobuhiko Shimizu

|Jun 27, 2024
Efficacy and Safety of Immuno-Oncology Plus Tyrosine Kinase Inhibitors as Late-Line Combination Therapy for Patients with Advanced Renal Cell Carcinoma.

Shuzo Hamamoto, Yoshihiko Tasaki, Toshiharu Morikawa

|May 11, 2024
C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study.

Toshiharu Morikawa, Taku Naiki, Yosuke Sugiyama

Pageof 1

Frequent Collaborators

5 joint publications

Toshiharu Morikawa

5 joint publications

Taku Naiki

5 joint publications

Takahiro Yasui

3 joint publications

Yosuke Sugiyama